Biobanking Market Size Key Major Challenges, Drivers, Growth Opportunities Analysis 2023-2033

The global biobanking market is estimated to garner a revenue of ~USD 88 Billion by the end of 2033 by growing at a CAGR of ~7% over the forecast period, i.e., 2023 – 2033.

Research Nester’s recent market research analysis on “Biobanking Market: Global Demand Analysis Opportunity Outlook 2033” delivers a detailed competitors analysis and a detailed overview of the global biobanking market in terms of market segmentation by product, specimen type, storage type, application, end-user, and by region.

Escalating Ratio of Genomics Research to Drive Growth of Global Biobanking Market

The global biobanking market is estimated to grow majorly on account of the significantly increasing ratio of genomics research activities for deep analyzation of DNA sequence data to figure out the variations that effects the human health, and to observe a drug’s response for effective treatment. According to the World Health Organization, the proportion of countries able to carry out genomic surveillance increased from 54% to 68% between March 2021 and January 2022 as a result of major funds invested during the COVID-19 pandemic.

Get a PDF Sample for more detailed market insights:

The market research report also includes other growth factors and challenges that are associated with the growth of the global biobanking market. Some of the major growth indicators are:

Growth Drivers:

Surge in Umbilical Cord Blood Cell Conservation

Significant Increase in Research and Development Across the Globe


The prevailing delusions regarding the biobanking, and extreme amount allied with the storage of specimen sample are some of the major factors anticipated to hamper the growth of the global biobanking market. Despite of the numerous restraint factors associated with the growth of the market, Research Nester’s analysis indicates a robust growth for the market during the forecast period

The market research report on global biobanking encompasses an in-depth analysis of the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends. These analyses help organizations identify a continuous flow of growth opportunities to succeed in an unpredictable future. Additionally, the growth opportunities exposed by the market is poised to gain significant momentum in the next few years.

Access our detailed report at:

Byspecimen type, the global biobanking market is segmented into blood products, human tissue, nucleic acids, cell lines, biological fluids, and others. The blood product segment is to garner a highest revenue by the end of 2033 by growing at a significant CAGR over the forecast period on the back of the potentially increasing occurrence of various kind of hematological diseases.

By region, the North America drug biobanking market is to generate the highest revenue by the end of 2033. This growth is anticipated by the spiking investment in RD activities, and escalating cognizance about the biobanking in the region.

The research is global in nature and covers detailed analysis on the biobanking market in North America (U.S., Canada), Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands Luxembourg, NORDIC [Finland, Sweden, Norway, Denmark], Poland, Turkey, Russia, Rest of Europe), Latin America (Brazil, Mexico, Argentina, Rest of Latin America), Asia-Pacific (China, India, Japan, South Korea, Indonesia, Singapore, Malaysia, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa). In addition, analysis comprising of global biobanking market size, Y-O-Y growth opportunity analysis, market players’ competitive study, investment opportunities, demand for future outlook etc. has also been covered and displayed in the research report.

This report also provides the existing competitive scenario of some of the key players of the global biobanking market which includes company profiling of Promega Corporation,VWR International, LLC, Merck KGaA, UK Biobank Limited, Thermo Fisher Scientific Inc., Tecan Trading AG, Hamilton Company, Bay Biosciences LLC, ISENET Biobanking S.r.l., ASKION GmbH, and others. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global biobanking market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.

Ask Customization and Browse full report with TOC List of Figure:

Research Nester is a leading service provider for strategic market research and consulting. We aim to provide unbiased, unparalleled market insights and industry analysis to help industries, conglomerates and executives to take wise decisions for their future marketing strategy, expansion and investment etc. We believe every business can expand to its new horizon, provided a right guidance at a right time is available through strategic minds. Our out of box thinking helps our clients to take wise decision in order to avoid future uncertainties.

Contact for more Info:

AJ Daniel


U.S. Phone: +1 646 586 9123

U.K. Phone: +44 203 608 5919

Khushi Gangwar

52 Blog posts